Neoadjuvant PD-1 inhibitor tislelizumab combined with s-1 plus oxaliplatin in patients with local advanced gastric cancer or gastroesophageal junction adenocarcinoma: Interim results of a single-arm, phase II trial

被引：4
|
作者：
Tao, Kaixiong
Yin, Yuping
Lin, Yao
Li, Wei
Li, Ruidong
Liu, Weizhen
Xiong, Zhen
Zeng, Xiangyu
Cai, Ming
Wu, Cuanqing
Zhang, Peng
机构：
[1] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Gastrointestinal Surg, Wuhan, Peoples R China
[2] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Wuhan, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2022年 / 40卷 / 04期
基金：
中国国家自然科学基金;
关键词：
D O I：
10.1200/JCO.2022.40.4_suppl.300
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
300
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Neoadjuvant tislelizumab and tegafur/gimeracil/octeracil (S-1) plus oxaliplatin in patients with locally advanced gastric or gastroesophageal junction cancer: Early results of a phase 2, single-arm trial
    Yin, Yuping
    Lin, Yao
    Yang, Ming
    Lv, Jianbo
    Liu, Jiaying
    Wu, Ke
    Liu, Ke
    Li, Anshu
    Shuai, Xiaoming
    Cai, Kailin
    Wang, Zheng
    Wang, Guobin
    Shen, Jianfeng
    Zhang, Peng
    Tao, Kaixiong
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [2] Efficacy and safety of S-1 plus oxaliplatin combined with apatinib and camrelizumab as neoadjuvant therapy for patients with locally advanced gastric or gastroesophageal junction adenocarcinoma: a protocol for a single-arm phase II trial
    Chen Chang
    Zhaolun Cai
    Ke Cheng
    Chaoyong Shen
    Bo Zhang
    Zhixin Chen
    Yuan Yin
    Dan Cao
    Updates in Surgery, 2025, 77 (1) : 165 - 174
  • [3] Efficacy and safety of camrelizumab combined with oxaliplatin and S-1 as neoadjuvant treatment in locally advanced gastric or gastroesophageal junction cancer: A phase II, single-arm study
    Zhong, Wen-Jin
    Lin, Jian-An
    Wu, Chu-Ying
    Wang, Jiantian
    Chen, Jun-Xing
    Zheng, Huida
    Ye, Kai
    CANCER MEDICINE, 2024, 13 (03):
  • [4] A single-arm, phase II feasibility study of neoadjuvant docetaxel, oxaliplatin, and S-1 (DOS) chemotherapy in potentially resectable gastric or gastroesophageal junction adenocarcinoma
    Ryu, M.
    Choi, Y.
    Kim, B.
    Park, Y.
    Kim, H.
    Jung, H.
    Lee, G.
    Kim, K.
    Yook, J.
    Kang, Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (04)
  • [5] Neoadjuvant PD-1 inhibitor and apatinib combined with S-1 plus oxaliplatin for locally advanced gastric cancer patients: a multicentered, prospective, cohort study
    Xu, Chao
    Xie, Xiaoli
    Kang, Ning
    Jiang, Huiqing
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023, 149 (07) : 4091 - 4099
  • [6] Neoadjuvant PD-1 inhibitor and apatinib combined with S-1 plus oxaliplatin for locally advanced gastric cancer patients: a multicentered, prospective, cohort study
    Chao Xu
    Xiaoli Xie
    Ning Kang
    Huiqing Jiang
    Journal of Cancer Research and Clinical Oncology, 2023, 149 : 4091 - 4099
  • [7] Multicenter phase II trial of S-1 plus cisplatin in patients with untreated advanced gastric or gastroesophageal junction adenocarcinoma
    Ajani, JA
    Lec, FC
    Singh, DA
    Haller, DG
    Lenz, HJ
    Benson, AB
    Yanagilhara, R
    Phan, AT
    Yao, JC
    Strumberg, D
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (04) : 663 - 667
  • [8] Conversion therapy of concurrent chemoradiotherapy combined with tislelizumab for unresectable gastric or gastroesophageal junction adenocarcinoma: A prospective, single-arm, phase II trial
    Liu, D.
    Yang, L.
    Lu, K.
    Zhao, Q.
    Yu, J.
    Liu, Y.
    Chen, Q.
    Liu, L.
    ANNALS OF ONCOLOGY, 2024, 35 : S173 - S173
  • [9] Phase II trial of S-1 combined with oxaliplatin (SOX) as neoadjuvant chemotherapy for locally advanced gastric cancer
    Chen, L.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (04)
  • [10] Phase II trial of docetaxel and oxaliplatin in patients with advanced gastric cancer and/or adenocarcinoma of the gastroesophageal junction
    Richards, D.
    McCollum, D.
    Wilfong, L.
    Sborov, M.
    Boehm, K. A.
    Zhan, F.
    Asmar, L.
    ANNALS OF ONCOLOGY, 2008, 19 (01) : 104 - 108
12345